A phase II, III clinical trial to assess immunogenicity, reactogenicity and safety of the measles, rubella vaccine, produced by Bio-Manguinhos

dc.creatorSantos, Eliane Matos dos
dc.creatorCamacho, Luiz Antonio Bastos
dc.creatorLucy, Clara
dc.creatorBrum, Ricardo Cristiano
dc.creatorXavier, Janaina Reis
dc.creatorConceição, Deborah Araújo da
dc.creatorOliveira, Patrícia Mouta Nunes de
dc.creatorMaia, Maria de Lourdes de Sousa
dc.creatorPetraglia, Tania
dc.creatorLuz, Kleber
dc.date2021-04-14T17:47:26Z
dc.date2021-04-14T17:47:26Z
dc.date2021
dc.date.accessioned2023-09-26T22:59:30Z
dc.date.available2023-09-26T22:59:30Z
dc.identifierSANTOS, E. M. et al. A phase II, III clinical trial to assess immunogenicity, reactogenicity and safety of the measles, rubella vaccine, produced by Bio-Manguinhos. In: INTERNATIONAL SYMPOSIUM ON IMMUNOBIOLOGICAL, 5., 2021. Rio de Janeiro. Annals... Rio de Janeiro: Bio-Manguinhos, 2021. p. 98.
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/46695
dc.identifier10.35259/isi.2021_46695
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8885599
dc.descriptionOs autores externos submeteram sua publicação para apresentação de trabalho no evento “International Symposium on Immunobiologicals”, que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.
dc.formatapplication/pdf
dc.languagespa
dc.publisherFiocruz/Instituto de Tecnologia em Imunobiológicos
dc.rightsopen access
dc.subjectSarampo
dc.subjectRubéola
dc.subjectVacina
dc.subjectISI
dc.subjectMeasles
dc.subjectRubella
dc.subjectVaccine
dc.subjectInternational Symposium on Immunobiologicals
dc.subjectSarampo
dc.subjectRubéola (Sarampo Alemão)
dc.subjectVacinas
dc.titleA phase II, III clinical trial to assess immunogenicity, reactogenicity and safety of the measles, rubella vaccine, produced by Bio-Manguinhos
dc.typePapers presented at events


Este ítem pertenece a la siguiente institución